Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (32,024) $ (22,793)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,614 726
Deferred rent and lease incentive (322) 541
Impairment of intangible asset 310 60
Stock-based compensation 1,228 547
Warrant expense 11  
Non-cash up front fee for note payable to Intrexon, including interest   10,100
Change in fair value of liabilities   (10,007)
Amortization of deferred financing costs   38
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 475 (226)
Other non-current assets   402
Accounts payable (2,633) 2,026
Accrued expenses (232) 648
Accrued expenses due to Intrexon 1,539  
Net cash used in operating activities (30,034) (17,938)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (1,949) (3,321)
Net cash used in investing activities (1,949) (3,321)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from IPO, net of underwriters' fee of $4,550   60,450
Proceeds from overallotment, net of issuance costs 4,738  
Proceeds from bridge financing   1,000
Borrowings under equipment term loan   1,750
Payment on equipment term loan (406)  
Issuance of Series A-1 preferred stock, net of issuance costs of $73   10,314
Costs associated with Initial Public Offering   (2,488)
Proceeds from the exercise of common stock options 39 26
Net cash provided by financing activities 4,371 71,052
Net (decrease) increase in cash and cash equivalents (27,612) 49,793
Cash and cash equivalents-Beginning of period 58,527 8,734
Cash and cash equivalents-End of period 30,915 58,527
Supplemental disclosure of Cash Flow Information:    
Cash paid for taxes 79 2
Cash paid for interest $ 94 18
Supplemental disclosure of noncash investing and financing activities:    
Warrant issued in connection with an equipment term loan (Note 10)   51
Issuance of a note payable to Intrexon as consideration for license rights   10,000
Extinguishment of Net Sales Distribution Payment Liability redemption feature   15,803
Adjustment to fair value of Series A-1 Preferred Stock related to the third closing (Note 11)   3,520
IPO [Member]    
Supplemental disclosure of noncash investing and financing activities:    
Conversion of preferred stock into common stock upon closing of IPO   70,905
Conversion of convertible notes payable and accrued interest into common stock upon closing of IPO   11,100
Conversion of warrants, net settled, into common stock upon closing of IPO   490
Settlement of Other Liability into common stock upon closing of IPO   612
IPO closing costs included in accounts payable and accrued expenses   $ 1,014